{
    "clinical_study": {
        "@rank": "92540", 
        "acronym": "CALIBER", 
        "arm_group": {
            "arm_group_label": "CALIBER", 
            "arm_group_type": "Other", 
            "description": "1 or 2 levels of DDD between L2 and S1, treated with transforaminal interbody fusion"
        }, 
        "brief_summary": {
            "textblock": "The primary objective of this study is to evaluate the safety and efficacy of CALIBER\n      expandable spacer for the treatment of degenerative disc disease. Radiographic outcomes,\n      intra-operative parameters, clinical outcomes, and patient satisfaction will be obtained\n      from patients in this 2 year follow-up clinical study."
        }, 
        "brief_title": "Efficacy and Safety of Expandable Spacer in the Treatment of Degenerative Disc Disease Using the Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgical Approach", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Degenerative Disc Disease", 
        "condition_browse": {
            "mesh_term": [
                "Spinal Diseases", 
                "Intervertebral Disk Degeneration"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients will be followed-up at 3weeks, 6 weeks, 3 months, 6 months, 12 and 24 months with\n      X-rays and questionnaires to determine their satisfaction, healing, fusion and return to\n      work status"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  DDD at 1 or 2 levels between L2 and S1\n\n          -  Between 18 and 80 years of age\n\n          -  Unresponsiveness to documented non-surgical treatment modalities for a minimum of six\n             months\n\n          -  Ability to provide a signed Informed Consent\n\n        Exclusion Criteria:\n\n          -  Trauma at level(s) to be fused\n\n          -  Previous documentation of osteopenia, osteoporosis, or osteomalacia to a degree that\n             spinal instrumentation would be contraindicated\n\n          -  Immunosuppressive disorder\n\n          -  History of substance abuse\n\n          -  Any known allergy to a metal alloy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02075554", 
            "org_study_id": "RGC10-009-001-PL_H_2"
        }, 
        "intervention": {
            "arm_group_label": "CALIBER", 
            "description": "Expandable interbody spacer", 
            "intervention_name": "CALIBER", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "February 27, 2014", 
        "location": [
            {
                "contact": {
                    "email": "dscspine@aol.com", 
                    "last_name": "Dan Cohen, MD", 
                    "phone": "305-532-7494"
                }, 
                "facility": {
                    "address": {
                        "city": "Miami Beach", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33140"
                    }, 
                    "name": "South Florida Spine Institute at Mt Sinai Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "dom.coric@cnsa.com", 
                    "last_name": "Dom Coric, MD", 
                    "phone": "704-376-1605"
                }, 
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28204"
                    }, 
                    "name": "Carolina NeuroSurgery and Spine Associates"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Study of an Expandable Interbody Device for the Lumbar Spine", 
        "overall_official": {
            "affiliation": "Mount Sinai School of Medicine", 
            "last_name": "Dan Cohen, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "X-rays and patient questionnaires to be done/completed", 
            "measure": "Fusion and disc height maintenance", 
            "safety_issue": "No", 
            "time_frame": "24 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02075554"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Questionnaires on health and healing status will be completed by patients at all follow-up visits", 
            "measure": "Patient Self Assessment", 
            "safety_issue": "No", 
            "time_frame": "Upto 24 mo"
        }, 
        "source": "Globus Medical Inc", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Mt. Sinai Medical Center, Miami", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Carolina Neurosurgery & Spine Associates", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Globus Medical Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}